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Abstract
MicroRNAs (miRs) and the canonical Wnt pathway are known to be dysregulated in human cancers and play key roles
during cancer initiation and progression. To identify miRs that can modulate the activity of the Wnt pathway we performed
a cell-based overexpression screen of 470 miRs in human HEK293 cells. We identified 38 candidate miRs that either activate
or repress the canonical Wnt pathway. A literature survey of all verified candidate miRs revealed that the Wnt-repressing
miRs tend to be anti-oncomiRs and down-regulated in cancers while Wnt-activating miRs tend to be oncomiRs and
upregulated during tumorigenesis. Epistasis-based functional validation of three candidate miRs, miR-1, miR-25 and miR-
613, confirmed their inhibitory role in repressing the Wnt pathway and suggest that while miR-25 may function at the level
of a ˆ-catenin (b-cat), miR-1 and miR-613 act upstream of b-cat. Both miR-25 and miR-1 inhibit cell proliferation and viability
during selection of human colon cancer cell lines that exhibit dysregulated Wnt signaling. Finally, transduction of miR-1
expressing lentiviruses into primary mammary organoids derived from Conductin-lacZ mice significantly reduced the
expression of the Wnt-sensitive b-gal reporter. In summary, these findings suggest the potential use of Wnt-modulating
miRs as diagnostic and therapeutic tools in Wnt-dependent diseases, such as cancer.
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Introduction
Colon and gastrointestinal cancers are amongst the leading
causes of cancer-related mortality and they all have been linked,
together with many other cancers, to mutations in components of
the Wnt/b-catenin pathway [1]. Therefore there is a major
interest in targeting the activity of this pathway using genetic and
chemical therapeutic tools. The promise of one emerging
approach rests upon the therapeutic potential of small interfering
RNAs (siRNAs) and microRNAs (miRs). miRs are small RNAs
(,ca. 22 nt in length) that regulate the level of mRNAs and
proteins by targeted degradation of specific mRNAs and/or
repression of their translation [2],[3]. Functions of miRs have been
identified in apoptosis, proliferation, differentiation [2] and stem
cell maintenance [4]. They have also been associated with cancer
progression and metastasis [5],[6],[7]. Steady-state expression
profiles of certain miRs have been often found to be deregulated in
cancers and can aid in prognosis [8],[9],[10]. Individual miRs that
have been reported to down-regulate oncogenes such as ras [11]
are called anti-oncomiRs and inhibit cancer proliferation. Others,
termed oncomiRs, function in a cancer-supportive or inductive
manner by down-regulating tumor-suppressors such as p53
[12],[13] and inducing proliferation and/or metastasis. The
canonical Wnt/b-catenin pathway is often found to be elevated
in gastrointestinal, breast and colon cancers among others and
there is strong evidence for a role of hyper-activated Wnt signaling
in cancer initiation and progression [14],[15],[16],[17],[18]. The
key element of Wnt signaling is the transcriptional co-activator
role of b-catenin, whose level is tightly controlled by a destruction
complex including a scaffold protein, Axin-1, APC, and GSK-3b,
a kinase that phosphorylates b-catenin, which results in its
ubiquitination and subsequent proteasomal degradation
[18],[19]. Wnt signaling via LRP5/6/Frizzled receptors and
cytosolic Dsh among other factors, destabilizes this destruction
complex, which leads to accumulation of b-catenin and its
association with TCF/LEF family transcription factors in the
nucleus to activate specific target genes [18],[19]. Negative
regulators of Wnt signaling like APC and Axin function as
tumor-suppressors and the viability of some cancer cell lines is
believed to be Wnt-dependent [20],[21],[22],[23],[24],[25].
It has been recently suggested that the delivery and use of anti-
oncomiRs or inhibiting oncomiR functionality with antagomiRs
[26] may serve as a promising therapeutic approach [27]. We
therefore hypothesized that identifying and characterizing miRs
that specifically modulate the canonical Wnt pathway could
provide a basis for the development of novel Wnt-based
therapeutics in Wnt-associated diseases, such as cancer. Research
in the past few years have implicated some miRs in the regulation
of Wnt signaling [28],[29],[30],[31],[32],[33],[34]. Here we
report a systematic screening of a library of 470 human synthetic
Pre-miRs and identification of 38 miRs that modulate the activity
of the Wnt pathway in human HEK293 cells. Secondary
validation and functional testing of 3 candidate miRs, namely
miR-1, miR-25 and miR-613 confirmed their inhibitory effect on
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that miR-1 and miR-613 target the pathway upstream of Axin or
active b-catenin, and that miR-25 acts downstream, at the level of
b-cat, likely by targeting b-cat’s coding sequence. Importantly,
overexpression of miR-25 and miR-1 inhibited proliferation/
viability of human colon cancer cells that are known to be
dependent on sustained b-cat signaling for their survival [22],[24].
Furthermore, expression of miR-1 in primary mammary epithelial
organoids derived from a Wnt-reporter mouse (conductin-lacZ)
significantly reduced the expression of the b-gal reporter. These
results suggest that these candidate miRs may influence Wnt
signaling activity in vivo.
Methods
Screening and reporter assays
Screening and reporter assays were carried out as described
previously [35]. Briefly, HEK293 cells trypsinized and resus-
pended in antibiotic-free culture media were plated and
transfected in 384 well plates (Corning, Cat No. 3704). Transfec-
tions were conducted with 0.1 mL Lipofectamine 2000 (Invitrogen)
and 27 ng STF19 reporter plasmid (a kind Gift from the R.T.
Moon laboratory, Seattle, USA) together with 5 ng Renilla-CMV
vector as internal control each well. 7 mL DNA-containing
transfection-mix with serum-free DMEM and Lipofectamine2000
was added to the pre-plated Hsa-pre-miR
TM in a 384 well plate
(5 mL each well, 1.5 pmol, human pre-miR library, n=470,
Ambion, #4385830) for a final concentration of 42.9 nM ca. 5000
viable HEK293 cells were plated in 23 mL culture media to the
pre-dispensed transfection mixes and incubated for two days.
50 mL of pretested Wnt3a-conditioned media (harvested from L-
Wnt3A cells [36], a kind gift from the laboratory or Dr. R. T.
Moon, University of Washington, Seattle) were added at day 2
post-transfection and cells were incubated for additional 16 hours.
Pre-miRs
TM used are synthetic siRNA-like and modified strand
selective small dsRNAs with verified specificity (Ambion). Cells
were lysed in 20 mL DualGlo (Promega, #E2920) substrate buffer
and normalized luminosity, which is the ratio of the firefly reporter
(STF16x-Firefly) and the renilla luciferase (CMV-driven), was read
with an EnVision multilabel plate-reader (Perkin Elmer). The ratio
of the STF-firefly and CMV-renilla RLU (relative light units) for
each Pre-miR was divided by the plate average (PA) or control
siRNAs, respectively. The primary screen was performed in
quadruplets for statistical/assay robustness. Cutoff values were
based on the performance of control siRNAs with the only
exception of the high/medium-scorer miR-200a that was also
included into the cherrypick-listing because of its described role
[29],[32]. Raw data, normalized values, and cherry-picking listings
are deposited available at the NYU-RNAi core facility, available
upon request, and found in the supplementary information (Fig.
S9). Other reporter assays, including epistasis experiments, were
conducted in 96- or 384-well plates using the same protocol
settings. STF19/CMV-RL activity in cancer cell lines was
measured one day post-transfection.
Cloning, DNA and RNA reagents
The coding region of human b-catenin (S37A mutant; transcript
nt position 307–1874 NcoI-Klenow; NotI) was subcloned into the
39UTR of the Renilla gene (NotI, SpeI-Klenow) within a psi-
check-2 reporter vector with modified MCS to monitor the
influence of miR-25 on its transcript stability and translation. In
this assay a CMV-driven synthetic-firefly-luciferase served as
internal control. A b-catenin fragment lacking exon-3 (543–1874)
behaved similar (not shown). A human Pri-miR-25 fragment was
PCR amplified from human genomic DNA (HEK293 cells) with
the following primer pair: FP-miR-25: 59-gcggccgccattctca-
gacgtgcctaag-39, RP-miR-25: 59-tctagatgattacc-caacctactgct-39.
After sub-cloning the hsa-Pri-miR-25 amplicon that contains
endogenous 59- and 39-flanking sequences was finally cloned into
the pcDNA3.1(-) vector (Invitrogen) via BamHI (vector and insert)
and NheI (vector) XbaI (insert). HPLC grade human synthetic
Pre-miR
TM precursor miRNAs that are strand-selection opti-
mized/approved and chemically modified siRNA-like precursor
miRs (Pre-miR-1
TM #AM17100; Pre-miR-25
TM #AM17100;
Pre-miR-613
TM #AM17100) were purchased from Ambion.
Three Axin1 and Axin2 Stealth siRNA (Invitrogen, Cat. No.:
119026-B03, -B05, -B01, -C07, -C11, -C09) were used as positive
control and epistatic-inductors to activate the canonical Wnt
pathway at its downstream components. Three Stealth siRNAs for
b-catenin (Invitrogen, 119026B07/B09/B11) were used to down-
regulated Wnt activity as positive control for a Wnt-pathway
inhibitory RNA. Silencer-Negative Control siRNA #4 (Ambion,
Invitrogen #AS00K2L1) and Silencer-Negative control siRNA
#2 (Ambion, Invitrogen #AS00JSIG) were used as negative
controls. The Pre-miR
TM precursor molecule library was plated in
5 mL with 1.5 pmol each well into two 384 well plates at the RNAi
screening core facility using an automated dispenser system (Janus
MDT, Perkin Elmer) and stored at 280uC. pLV-miR-1 and pLV-
miR-control lentivirus were obtained from Biosettia (San Diego,
USA).
Bioinformatics, and statistical analysis. Sequences were
aligned with ClustalW, visualized and processed with Genedoc
software, and Treepuzzle and Treeview software were employed
for similarity and phylogenetic analysis (parameters: 10.000
puzzling steps; quartet puzzling tree reconstruction, neighbor-
joining tree, approximate quartet likelihood, HKY-model of
substitution). miRNA target prediction and alignment blasts
were done with miRWalk, Pictar, Diana-microT, PITA,
RNAhybrid, Target Scan, miRanda, NCBI-blasts. Statistical
analysis: Z-factors were calculated with Z=1-(3(sp+sn)/(|mp-
mn|)) and values between 0.5 and 1.0 indicated good screening
parameters. Log-Z-score was deployed on log-tansformed (Nexp
FF/RL) data set. Z=((FF/RL)LOG-PALOG)/STDEV(PLOG); FF,
TCF19x-firefly RLU; RL, CMV-Renilla RLU; PA, plate average;
RLU, relative light units; STDEV(P) standard deviation of the
plate. Local plate averages (7–10 data points) were used for
alternative balancing of normalized data of the primary screen.
Regulation of transcript level/translation is measured by the psi-
check-2 reporter and determined by relative changes of RLU
values via R(r)=(RL-b-catCDS/FF)/(RL-empty/FF); with R(r) of
controls=1. Pubmed (NCBI) and Google searches were used for
data mining to find cancer relevant reports on miRs identified and
verified for correlation studies.
Western blotting. SDS-PAGE and western blotting was
performed with standard protocols including TBST (0.1%)
washing buffer and 4% BSA TBST blocking buffer. Primary
antibodies (anti-b-catenin, Sigma, #C7207, anti-tubulin (a-
Tubulin), Sigma, #T9026) were incubated over night while
gently shaking at 4uC in 1:1000 to 1:2000 dilutions. Infrared (IR)-
dye conjugated secondary antibodies (1:20.000, goat anti-mouse,
IRDye
TM800, #610-132-121, Rockland) were incubated at room
temperature for 1 h in blocking buffer and subsequently rinsed
with TBST. Blots were visualized with the Odyssey infrared
imaging system and quantified with the Odyssey software (Li-Cor,
Biosciences). For semi-quantitative western blotting the average of
the ratios of b-catenin and a-Tubulin (a-TUB) [signal intensity]
was divided by the average of the ratios of the control experiments.
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kidney cells (ATCC, cat # CRL-1573), HCT116 human colon
cancer cells (ATCC, cat # CCL-247), SW480 human colon
cancer cells (ATCC, cat # CCL-228), and MCF7 human breast
cancer cells (ATCC, cat # HTB-22) were cultured in filtered
DMEM media supplemented with 10% fetal calf serum, 1 mM L-
glutamine and 16 non-essential amino acids (ATCC, #203166)
without antibiotics at 37uC and 5% CO2. Selection media for cells
transfected with linearized empty pcDNA3.1(-) or Pri-hsa-miR-25
pcDNA3.1(-) using Lipofectamine2000 contained increasing
amounts of active G418 sulfate (Cellgro #30-234-CR) for 7–16
days. Lenti-pLV-miR-1 and -pLV-control transduced cells were
selected with puromycin for up to 7 days.
RT-qPCR. Real-Time relative quantification PCR was
conducted with 25 mL iTAQ
TM SYBR-Green Supermix (16)
with ROX (BIO-RAD, #20361) and the qPCR thermocycler
Mx3005P (Stratagene) system including the MxPro-Mx30055
v.4.10 Build 389 software (Stratagene) and the delta-delta-Ct
calculation method. Thermocycler conditions: 96uC initial
denaturation step for 10 min, 50 cycles of (96uC denaturation for
30 s, 57uC annealing for 30 s and 72uC elongation for 10 s).
Amplification and dissociation curves revealed the specificity of the
qPCR products, which were also examined by DNA agarose TAE
gel electrophoresis (2% agarose, with EtBr). Unmodified exon-
spanning primer pairs with similar annealing temperature (57uC)
and product size (80–110 bp) were used. Total RNA was isolated
with RNeasy (Qiagen) and cDNA was synthesized using the High-
capacity cDNA reverse transcription kit (Applied Biosystems,
#4368814). Briefly, 1 mg of total RNA was DNaseI digested, heat
inactivated, and input for cDNA reverse transcription in 20 mL
following the instructions of the manufacturer. Primer sequences:
CTNNB1-fw 59-ATGGCAACCAAGAAAGCAAG-39; CTNNB1-
rv 59-GGTCCACAGTAGTTTTTCGTAAG-3 (product size
101 bp); internal control primer: GAPDH-fw 59-TGAAGGTC-
GGAGTCAACG-39, GAPDH-rv 59-GGGTCATTGATGGCA-
ACA-39 (product size 97 bp).
In vivo context analysis of the regulation of axin2/
Conductin-lacZ reporter by miR-1. Two axin2/Conductin-
lacZ mature female mice [37] were sacrificed and mammary
epithelial organoids prepared essentially as described [38]. Six
mammary glands/mouse were collected in DMEM/F12 10% FBS
medium on ice. The glands were transferred to a sterile Petri dish
and minced into a homogenous paste using a pair of sterile
scalpels. The minced tissue was transferred to a 15 ml falcon tube
containing 9 ml Epicult–B Basal Medium (Stem Cell
Technologies) and 1 ml of 106 collagenase and hyaluronidase
(3000 and 1000 units/ml Stem Cell Technology) and constantly
agitated (environmental shaker) for 1 h at 37uC. The tissue was
then collected by centrifuged at 450 g for 10 min and re-
suspended in cold HBSS 2% FBS. The organoids were isolated
from contaminating fibroblasts and blood cells by 2 s pulse
centrifugation at 450 g (repeated 5–7 times) their purity was
assessed by examination on a glass slide. The final pellet was re-
suspended in 2 ml Trypsin/EDTA (0.25%) and incubated at 37uC
for 1 min. The sample was then diluted in 10 ml of cold HBSS
containing 2% FBS and spun down at 450 g for 5 min. The
supernatant containing stringy DNA was removed carefully and
the remaining pellet was re-suspended in pre-warmed fresh dispase
containing 500 ml (2000 unit/ml) DNase, mixed for 1 min and
spun down. Organoids were then re-suspended and plated in
Epicult-B Basal Medium. Control and miR-1 expression vectors
(pLV-miR-1 from Biosettia Inc., USA) were used for lentiviral
transduction of the cells in 24-well plates. After 12 h of incubation,
the cells were fixed in 4% formaldehyde (Electron Microscopy
Sciences) for 20 min, washed 3 times with 16PBS, permeabilized
and blocked with blocking buffer (0.1% Triton X-100, 1% BSA,
5% normal goat serum in DPBS) at room temperature for 20 min
and immuno-stained with mouse anti-b-GAL 1:50 (DHSB, 4uC
overnight), anti-mouse IgG-Alexa488 goat antibody (Invitrogen;
1:1000; 2 h at room temperature) and DAPI. The cells were
imaged using a Nikon TE2000PFS and the levels of b-gal
(fluorescence intensity) was measured by the NIS elements
software (Nikon, USA).
Results
Identification of human microRNAs in a primary Wnt-
reporter screen
Micro-RNAs (miRNAs, miRs) and the Wnt pathway play
fundamental roles in development and disease by regulating
expression of target genes. We hypothesized that certain miRs
could fine-tune the activity of b-catenin-dependent ‘‘canonical’’
Wnt signaling by modulating the abundance of relevant pathway
components. To address this question we performed a luciferase
reporter screen in human HEK293 cells to investigate the
regulatory capacity of a library of 470 miRs on the activity of
the canonical Wnt pathway. HEK293 cells were transiently co-
transfected with individual synthetic Pre-miR
TMs, a luciferase
gene reporter driven by 16 functional TCF/LEF1 binding sites
and a CMV-Renilla luciferase that served as internal control for
cell viability and transfection efficiency. The canonical Wnt
pathway was activated with Wnt3a-conditioned media from L-
cells 2.5 days post-transfection, and plates were read after 16 h of
Wnt3a-CM treatment at day 3. The primary screening was
performed in quadruplets in a 384-well plate format and yielded a
set of 60 (of 470) candidate Wnt-regulatory human miRNAs (30
activators/synergists and 30 repressors), representing 12.8% of the
strand-selective, synthetic Pre-miR
TM Library (Ambion) (Fig. 1A,
Fig. S1). A sector of the averaged and normalized screening results
and a representation of the Z-score of the entire log-transformed
data set is shown in Fig. S1 (B, C). The pCMV-Renilla-normalized
Wnt/miR-screening results are available in the supplementary
material S9. Following verification of consistent ‘‘hit’’ reproduc-
ibility, in a second round of low-throughput screening, 38 of the
original 60 Pre-miRs were validated as unidirectional regulators,
representing a validation rate of 63.3% which is about 8% of the
entire library (Fig. 1A, B). Positive controls with b-catenin siRNAs,
Axin1/Axin2 siRNA, and negative siRNA controls showed
expected and reproducible results (Fig. 1 B, inset). The z-factor
for the high throughput screen (HTS) was determined to be
z.0.55 suggesting a robust setup for HTS and was also utilized for
cut-off designations together with the normalized values of all
positive controls.
Wnt-modulation by miRs correlates with
miR-oncogenicity and sequence similarity
Having determined the initial list of verified Wnt-modulating
miRs (Fig. 1B), we examined possible correlations between the
candidate miRs. An alignment of all mature miRs revealed a
significant enrichment of sequence similarities within all validated
miRs, some of which are members of the same family. Notably, we
found that sequence similarity between miRs correlates with their
ability to either activate or inhibit the activity of the Wnt-pathway
(Fig. 2). An unbiased alignment of all identified mature miR
sequences, shown in Fig. 2A, indicates several obvious consensus
sequence conservations amongst all validated candidate miRs.
MiRs with high sequence similarity can be also easily identified in
a quartette puzzling tree, Fig. 2B, where nucleotide substitution is
MiRNA Regulators of the Wnt Pathway
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repressing miRs are indicated by a green disc and Wnt-activators
are indicated by a red disc. Thus it became apparent that high
sequence similarity often goes in parallel with unidirectional
modulation of the Wnt pathway (Fig. 2B). Most obvious and
interesting sequence similarity examples are also shown in Fig. 2C.
Specifically, this correlation or trend was very clear for 6 miRs,
miR-302a,-302d, -519e, -519b, -517a, and -371 e.g.; they all
hyper-activated the Wnt-reporter and happen to exhibit high
sequence similarity (Fig. 2C). Of these, miR-302a and miR-302d
are members of the miR-302 family and miR-519e, -519b, and
-517a belong to the miR-515 family. A closer look at sequence
similarity analysis of the whole miR-515 family revealed a striking
consensus sequence between related Wnt-activating miRs (Fig.
S8). Moreover, this consensus sequence is also highly shared by the
miR-activators of the miR-302 family. Hsa-miR-371 is part of the
miR-290 family, in agreement with alignments and phylogenetic
Stem Loop (SL)-miR trees (Fig. S3), but also inherits, what we
would suggest, a newly identified ‘‘Wnt-activator associated
signature’’ (GUGCNNCCN(N)(N)UUU(N)NNG). Curiously, this
activator consensus sequence is discontinuous and consists of the
39-half of the major and highly conserved miR-seed sequence and
a more 59-part of a ‘‘co-seed’’ sequence, which is part of the
mature miR and 39-downtstream of the major-seed. This
consensus sequence could thus play a role in target mRNA
recognition in addition to its putative function in the formation of
the loop structure of the stem-loop miR precursor. A comparison
of Pre-miR-SL and mature miR sequence alignments and trees
Figure 1. Validation of the Pre-miR/Wnt3a/STF-report screen in HEK293 cells. (A) Schematic overview of the screening and validation
procedure. (B) Target listing of all validated synthetic cherry-pick Hsa-Pre-miRs and the average of all measurements with SEM (N=2, n=8). Color-
code: Hsa-Pre-miRs that significantly repressed (green tab) or activated (red tab) the STF reporter of canonical Wnt-pathway activity. Green disc: anti-
oncomiR; red disc: oncomiR. Inset: Representative performance of control siRNAs in one of the assays with LiCl or Wnt3a pathway induction. (C)
Simplified sketch of important Wnt/b-catenin pathway nodes/switches and its activation sites by axin1/2 siRNAs or LiCl (D) Correlation between Wnt-
pathway repressor (R) and activator (A) miRs being anti-oncogenic (anti-oncomiRs) or oncogenic (oncomiRs). Within each column the fraction of Pre-
miRs whose expression is up- or down-regulated in cancer is indicated by color.
doi:10.1371/journal.pone.0026257.g001
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consensus and seed sequences (Fig. S3). Importantly, the majority
of these similar mature miRs and SL-miRs shows a modulation of
the canonical Wnt pathway in the same direction (Fig. S3, inset),
which could indicate a causal relationship between sequence
similarity/specificity and similar function.
Interestingly, further data mining via literature searches
revealed another outstanding and surprising coherency that also
supported our initial hypothesis: a majority of the miRs that have
been reported to be anti-oncogenic and are repressed in cancers
displayed Wnt-inhibitory properties, whereas those described as
oncogenic miRs and are often elevated in cancers were identified
as activators of the Wnt pathway by trend (Fig. 1D, for references
see Table in Supplementary Fig. S6).
Secondary validation of miR-1, miR-25 and miR-613
We chose to further investigate three candidate miRs that
repressed Wnt3a/b-catenin signaling in the primary screen: miR-
1, miR-25 and miR-613. Phylogenetic analysis support the miR-
base classification that miR-1 belongs to the miR-1/206 family
including hsa-miR-206 and the Drosophila dme-miR-1, an
indication of the high evolutionary conservation of this family
(shown in Supplementary, Fig. S2A by alignments and phyloge-
netic quartette puzzling trees); hsa-miR-25 belongs to the
evolutionary conserved miR-25/92 family [39] including Drosoph-
ila miR-92a+b/310/311/312/313, shown in Fig. S2B, and shares
only the seed sequence with other miRs like miR-4325 or miR-
367. MiR-613 showed the strongest inhibition in the primary
validation assay (Fig. S1) and shares the same seed sequence as the
miR-1/206 superfamily (59-GGAAUGU-39) but shows no addi-
tional overall conservation (Fig., S4). On the other hand miRs like
miR-32 or 367 that shares the seed with the miR-25/92 family
could not repress Wnt reporter activity (Fig.S4). This could
indicate that some miRs or miR-families may repress the Wnt
pathway components/activity mainly with the seed sequence
(miR-1/613-family), while others may require the coordinated
action of the seed and co-seed (miR-25/92-family).
To understand at which step these miRs (miR-1,-25,-613)
modulate the linear cascade of the Wnt pathway, and to identify
their potential target genes, a series of epistasis experiments were
conducted in HEK293 cells using the Wnt reporter and different
pathway activators (Fig. 3 A, B). Induction of the Wnt pathway
with Wnt3a-CM or by the GSK3b-inhibitor Lithium salt (LiCl)
could be repressed by all three miRs. Elevated reporter activity by
simultaneous siRNA mediated knockdown of Axin1 and Axin2
could be strongly inhibited by transfection of Pre-miR-25 (P,0.05;
unpaired t-test), while miR-1 and miR-613 showed no significant
influences (P.0.05). While Axin1 and GSK3b occupy similar
complexes at the plasma membrane with LRP6, and with b-
catenin in the cytosolic destruction complex, their functions may
diverge elsewhere, such as in the nucleus where Axin-1 is also
thought to be involved in nuclear export mediated repression of b-
Figure 2. Alignment and tree of all validated Wnt-regulating Pre-miRs to represent and visualize sequence similarities. Numbers
indicate Pre-miR designation. I. e. 233 stands for the mature hsa-Pre-miR-223 strand. Green: Pre-miR that was identified and verified as Wnt-inhibitory
in the STF reporter assay. Red: Pre-miR that was identified as Wnt-activator/synergizer (A) Alignment of all mature strand selected verified Hsa-Pre-
miRs (B) Quartet puzzling tree phylogram determined with tree-puzzle to visualize the degree of sequence similarities between all Pre-miRs based on
nucleotide substitutions (C) Representative examples of miRs that share a high degree of sequence similarities. Note the enrichment of sequence
similarity with unidirectional Wnt pathway modulation (see also Fig. S3).
doi:10.1371/journal.pone.0026257.g002
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additional role of Axin downstream/independent of GSK3b.I n
agreement with this, Axin1/2 siRNAs could further synergize
pathway activation in Wnt3a (7-fold activity) and LiCl (270-fold
activity) induced cells to a very similar extent (Fig. 1 B inset),
indicating that Axin inhibition, activates the pathway additively
irrespective of the level of GSK3b-inhibition. Additionally, only
miR-25 inhibited the activity of degradation-resistant S37A b-
catenin mutant on the STF reporter (Fig. 3 A). Taken together,
these data suggest that miR-25 represses the Wnt pathway
downstream of GSK3b, Axin1/2 and stabilized b-catenin, while
miR-1 and miR-613 act upstream of Axin1/2 and stabilized b-
catenin but probably downstream of LiCl-mediated inhibition of
GSK3b.
Relative quantification with real time quantitative PCR (RT-
qPCR) did not reveal any significant reduction in b-catenin
(CTNNB1) mRNA level in HEK293 cells (Fig. S7), nor for BCL9,
Lef-1, TCF-1 (TCF7), Pygo1, Pygo2, Maml1, TCF-3, (TCF7l1)
Figure 3. Molecular and functional characterization of candidate Wnt-regulatory miRs. (A) Epistasis experiments with synthetic human
Pre-miR-1, Pre-miR-25 and Pre-miR-613. Influence of miRs on different epistatic pathway stimulations with Wnt3a, LiCl, Axin(1+2)-siRNA or S37A
stabilized b-catenin that escapes default ubiquitination and degradation. (B) Semi-quantitative Western blotting to measure relative total b-catenin
protein level changes (b-catenin normalized with a-Tubulin level) in HEK293 cells transfected with 50 nM Pre-miR-1, Pre-miR-25 or Pre-miR-613 at day
3 using different pathway inductions (for 1 day) as indicated. (C) Semi-quantitative Western blotting measurement of relative total b-catenin protein
level changes in SW480 colon cancer cell (APC deficiency). (D) STF19x reporter assay normalized by CMV/Renilla to measure endogenous pathway
activity in Pri-miR-25 stable cancer cell lines (SW480, HCT116) compared to empty vector control stable cells. (E) Psi-check2 reporter assay system to
measure the influence of b-catenin CDS mRNA fragment (inserted into the 39UTR of a Renilla gene) on transcript translation in the presence of
indicated miRs. Left: Blue columns represent the empty vector control. Red columns indicate the psi-check2-CTNNB1-CDS vector. Right: normalized
psi-check2-CTNNB2 vector values are shown. (F) Viability of transfected cancer cells during G418 selection. Relative amount of cells obtained after the
selection procedure to establish HCT116, SW480, and HT29 colorectal cancer cell lines expressing Pri-miR-25-pcDNA3.1(-)-Neomycin compared to
empty vector control cells. Asterisk: unpaired student’s t-test, (P,0.05).
doi:10.1371/journal.pone.0026257.g003
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TCF-4 (not shown). While miR-1 and miR-613 could slightly
reduce Wnt3a-CM mediated induction of b-catenin protein levels
in HEK293 cells, miR-25 and miR-613 expression resulted in a
moderate (,20%) reduction in LiCl induced total b-catenin
protein level, (Fig. 3B).
The epistasis experiments indicated that miR-25 may act in
parallel or downstream of b-catenin itself. Intriguingly the most
stringent RNAhybrid predictions that allow non-canonical seed
sequences indicated some potential binding sites of miR-25 in the
b-catenin cDNA (Fig. S5), while other target prediction algorithms
(PicTar, EMBL-Microcosm, etc.) did not predict b-catenin as a
target, because there is no distinct site in its 39UTR. To test
whether miR-25 could directly target the b-catenin cDNA, a
fragment of the b-catenin coding sequence (CDS) containing the
potential miR-25 binding sites was cloned into the psi-check-2
reporter. Renilla gene activity with an inserted b-catenin CDS in
the 39UTR indicated a significant miR-25-dependent reduction
while control siRNAs, miR-1 or miR-613 had no effect (Fig. 3E).
Notably, not only synthetic Pre-miR-25 but also over-expression of
Pri-miR-25 could reduce a normalized Renilla gene activity with
the b-catenin-CDS-fragment-39UTR but to a lesser degree. As
RT-qPCR experiments revealed no significant change in b-
catenin transcript levels for all three miRs (Fig. S7), one remaining
possibility is that miR-25 represses translation of b-catenin but not
its transcript level. As b-catenin is predominantly and tightly
regulated via post-translational regulation it is likely that
translational reduction might play a minor role in uninduced or
moderately induced cells, such as by Wnt3a-CM which induces
reporter activity by only 7-10-fold (Fig. 3B); while during extensive
pathway activation via LiCl, which can induce a .200-fold
induction in the STF-assay, translational differences could play an
increasingly relevant and important function in modulating the
steady-state protein levels and are thus then detectable in our
assays.
Investigating functions of miR-1 and miR-25 in
Wnt-relevant colon cancer cell lines
In order to investigate the function of miR-25 in Wnt-responsive
cell lines we cloned a human unprocessed Pri-miR-25 into the
pcDNA3.1(-) expression vector with a selectable neomycin marker.
Upon transfection of colon cancer cells (HCT116, HT29, SW480)
with Pri-miR-25 expressing vector, the number of Pri-miR-25
stable cell-colonies was markedly reduced compared to empty
vector controls (Fig. 3F). This was particularly evident in HT-29
cells where despite several attempts we could not generate HT29-
pcDNA3.1(-)-hsa-miR-25 expressing stable cell lines, although a
few pcDNA3.1(-) empty vector transfected clones survived the
selection procedure (Fig. 3F). HT29 cells are known to be
dependent on APC-deficiency induced b-catenin activity for their
survival, as reintroduction of a cDNA coding for a wild-type APC
induces apoptosis [22], which could explain our observation.
Additionally, expression of Pri-miR-25 in SW480 colon cancer
cells, that exhibit high Wnt/b-catenin activity due to an APC
truncation, significantly inhibited both the STF Wnt-reporter
activity by ,40% (Fig. 3D) and b-catenin protein levels by 20%
(Fig. 3C). However HCT116 colon cancer cells that are known to
exhibit high levels of endogenous Wnt pathway activity due to an
intrinsic mutation in the b-catenin gene (DS45) showed no
reduction in the STF and b-catenin expression levels.
We also investigated the potential function of the candidate
Wnt-inhibitor miR-1 in the Wnt-dependent HT29 cancer cell line,
because miR-1 was identified as one of the strongest repressors of
Wnt-3a-induced activation of the STF reporter (Fig. 4). HT29 cells
stably expressing intronic miR-1 in the 59-UTR of rPURO, a red
fluorescent puromycin-N-acetyl-transferase, were generated.
These cells express red fluorescence and exhibit puromycin
resistance. Hsa-miR-1 expressing cells displayed markedly reduced
viability at day 4. While control-virus infected HT29 cells
exhibited normal proliferation and colony-formation efficiency at
day 7, Pre-miR-1 expressing HT29 cells did not show any obvious
signs of proliferation (Fig. 4A–C). HEK293 cells that stably express
hsa-miR-1, while showed an initial reduction in cell proliferation
at day 4 of selection compared to control, did not display any
major proliferation defect by day 7. These results may suggest that
the compromised viability in HT29 cells, as compared to HEK293
cells, can be due to a specific Wnt-dependence of HT29 colon
cancer cells for their survival (Fig. 4D).
miR-1 inhibits expression of a Wnt-responsive reporter
(conductin-lacZ) in primary mammary organoids
To test whether candidate miRs can influence Wnt signaling in
an in vivo context we derived primary mammary epithelial
organoids from the axin2/conductin-lacZ mouse [37] using
protocols described in Teissedre et al. [38]. Conductin-lacZ has
been previously shown to respond to activated-Wnt signaling in
mammary epithelial tissue. We introduced a miR-1 expression
construct into mammary epithelial organoids derived from the
conductin-lacZ in vivo reporter mouse using lentiviral transduction
(pLV-miR-1 from Biosettia Inc., USA) and investigated whether
expression of miR-1 could influence the expression of the b-gal
reporter compared to pLV-empty vector control. As shown in
Fig. 5, while pLV control vector (as followed by DsRED
expression) did not influence the expression of b-gal reporter
(green) (Fig. 5A-A00), expression of miR-1 within the organoids
strongly repressed reporter activity (Fig. 5B-B00) (see quantification
in Fig. 5C). In fact in most cases, miR-1 transduced organoid
colonies exhibited almost no immuno-reactivity towards b-gal
under identical exposure conditions. These data strongly suggest
that ectopic expression of miR-1 may be sufficient in inhibiting the
Wnt-responsive reporter in an in vivo context.
Discussion
In this report we provide the results from a comprehensive
screen for the identification, and validation/characterization of
human Wnt pathway-modulating miRNAs using a systematic
HTS approach. Three candidate Wnt-repressing miRs, namely,
miR-1, miR-25 and miR-613, were further characterized in cell-
biological assays. In addition to the known Wnt-modulatory
miRNAs, such as miR-200a [29],[32], Drosophila miR-315 [28],
miR-8 [30], miR-27 [31], zebrafish miR-203 [33], and miR-34
[34], we identified 37 additional miRs that modulate the activity of
the Wnt-pathway reporter in cultured human cells. The functions
of these 37 miRs, their potential evolutionary conservation, as well
as their putative target genes can now be addressed in future
studies.
Notably, we uncovered an interesting correlation between many
of the candidate miRs that exhibit sequence similarities, both
within and outside their mature seed sequence, and their ability to
exert similar modulating influence on the activity of the Wnt3a/b-
catenin pathway, thereby indicating sequence specificity in miR-
mediated Wnt-pathway modulation. The consensus sequences
may indicate novel functional seed and ‘‘co-seed’’ sequences that
may be involved in the modulation of the Wnt pathway. The
partly disrupted consensus seed and co-seed sequences might
reflect the imperfect base-pairing with their cognate target genes
that participate in Wnt signaling. Moreover, alignment of miRs
MiRNA Regulators of the Wnt Pathway
PLoS ONE | www.plosone.org 7 October 2011 | Volume 6 | Issue 10 | e26257that could regulate the Wnt reporter made intra- and inter-family
related functional consensus sequences apparent (i.e. the seed of
miR-1 and miR-613 or within the miR-302 and -515 families (Fig.
S8)). This allows the generation of testable hypotheses regarding
the functional relevance of specific nucleotide substitutions in miRs
within the same family (Fig. S4).
Interestingly, our data also revealed that Wnt-inhibitory miRs
tend to be anti-oncomiRs and Wnt-activating miRs tend to be
oncomiRs. While the target-directness of each miR needs to be
identified and validated in future studies, these data suggest that
oncomiRs could contribute to elevated Wnt-pathway activity in
cancers (Fig. 1), whereas anti-oncomiRs could function in
buffering high levels of Wnt activity by keeping the expression of
pathway components in check. Deregulated miR expression
profiles might also contribute to oncogenesis by repressing the
tumor suppressors, p21/p53 (miR-25 [42],[43], miR-504 [44])
which in turn might affect Wnt signaling. Disruption of cell cycle
regulation may also stem from deregulated Wnt activity [45]. As
the Wnt pathway is known to be pro-proliferative, and has target
genes like c-myc and cyclin-D1 [24],[46], in certain contexts
including cancers, the fine-tuning or buffering of Wnt activity by
several distinct miRs could modulate proliferative potential of
tumor cells, which might also explain the observed correlation.
Further studies addressing the identities of the direct targets of
candidate miRs can clarify their precise function(s) in the
regulation of the Wnt pathway in oncogenesis. This could be
addressed in global biochemical approaches such as SILAC or
AGO-RIPA (also via HITS/PAR-CLIP [47],[48]) in cytosolic
DGCR8 or Drosha loss of function cells transfected with synthetic
miRs to identify direct targets.
Figure 4. Characterization of miR-1 overexpression in HT29 and HEK293 cells. (A) HT29 colon cancer cells expressing pLV-Hsa-Pre-miR-1 or
control vectors at day 4 of puromycin selection. (B) HT29 cells expressing pLV-Hsa-Pre-miR-1 or control at day 7 of puromycin selection. (C)
Quantification of HT29 cells at day 4 and 7. RFP (red) fluorescence indicates the expression of RFP harboring the intronic miR-fragment. (D) HEK293
cells expressing miR-1 or control at day 3 (left) and day 7 (right) post puromycin selection. RED RFP fluorescence indicates expressing HEK293 cells. (E)
LiCl induced Wnt pathway activity in stable miR-1expressing HEK293 cells.
doi:10.1371/journal.pone.0026257.g004
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further characterized in Wnt-responsive cultured cells and all
were validated for their Wnt-inhibitory properties identified in
the initial screen. Epistasis experiments revealed that candidate
miRs target the signaling network at different sites. Pre-mir-1
may function most upstream, followed by miR-613 and then
miR-25, which seems to influence the most downstream activity
at the level of b-catenin. All miRs down-regulated Wnt3a-CM
and LiCl induced Wnt pathway activity, while only Pre-miR-25
was able to repress Axin1+2-siRNAs or b-catenin-S37A induced
activity. Hsa-Pre-mir-1 had a lesser ability to reduce total b-
catenin protein levels under conditions of high pathway
activation with LiCl. Interestingly, the results from this set of
epistasis experiments are in agreement with a known function of
Axin downstream/independent of the GSK3 b-catenin destruc-
tion complex (Fig. 1C), probably via nuclear-export mediated
reduction (Fig. 1B, inset). Hsa-miR-1 and -613 seem to be not
closely/directly related but share identical seed sequences and act
upstream of Axin and probably downstream of GSK3 (as judged
by their inhibitory effect on LiCl mediated activation of the
reporter). Therefore both miRs may target a component of the
Wnt-pathway upstream of b-catenin via their identical seed
sequence, although the precise and relevant molecular targets
remain to be identified. That said, it is important to note that
cMET has been previously suggested to be a direct target of miR-1
[49],[50],[51].
Figure 5. Lentiviral expression of miR-1 inhibits expression of the Wnt reporter, axin2/Conductin-LacZ in primary mouse mammary
epithelial organoid cultures. (A-A00) Representative image of organoid transduced with pLV-dsRed (Control) vector. (B-B00) Representative image
of organoid transduced with pLV-miR-1-dsRed lentiviral vector. The organoids transduced with control lentiviral vector (A0) shows significantly higher
expression of Axin2-b-gal compared to organoids expressing miR-1 (B0). The dotted lines in panel A represent non-cellular auto-fluorescence, which
was excluded from analysis of fluorescence intensity measured by NIS Elements Software. (C) Quantitative measurement of mean levels of b-gal
(fluorescence intensity) in six individual organoids transduced with pLV-dsRed (Control) and seven individual organoids transduced with pLV-miR1-
dsRed lentiviral vector. The average intensities were calculated for Region of interest (ROI) selected for each organoid using dsRed expression (that
represents lentiviral infection) using the NIS Elements Software. Error bars denote standard deviation among samples.
doi:10.1371/journal.pone.0026257.g005
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pathway suggests a potential function in the translational
inhibition of b-catenin via its binding to the b-catenin coding
sequence and not its 39-UTR. Expression of miR-25 repressed the
psi-check2 sensor containing the miR-25 binding site, and
moderately reduced b-catenin protein levels, while b-catenin
transcript levels remained unchanged. Curiously the effect of hsa-
miR-25 on b-catenin seems to be more effective under conditions
of high pathway and low destruction complex activity, when
translational differences preponderate and come into play due to
strongly reduced post-translational regulation of b-cat. Reduced b-
cat protein amounts can thus be better resolved in LiCl-induced
HEK293 cells with high pathway activity, while a low pathway
activity by Wnt-3a-CM (ca. 10-fold in STF assay, LiCl ca.50–100-
fold) could only be reduced by miR-1 and miR-613 that can block
a more upstream part of the pathway and are thus more efficient
(Fig. 3D). A downstream role of miR-25 is also in agreement with
a Drosophila miR-25/92 evolutionarily related cluster (Fig. S2)
that can target the Wnt/Wg pathway (Pancratov and DasGupta,
unpublished data). Recent evidence also suggests that miR-25 may
inhibit Wnt/b-catenin dependent cancer viability by targeting
Pcaf [52] which binds, acetylates, stabilizes and activates b-cat
[53], thereby corroborating our observation that the influence of
miR-25 is likely at the level of b-cat. Intriguingly, miR-32, that
inherits the same seed as miR-25 also targets Pcaf [52] but instead,
upregulates the Wnt-reporter in our reporter assays (Fig. S4).
These observations suggest that the coding sequence of b-catenin
itself may be the primary and direct target of miR-25.
Additionally, the opposite effects of miR-25 and miR-32 on the
Wnt reporter may imply an important and distinguishing role for
the co-seed sequence of miR-25, which is strongly divergent
between miR-25 and miR-32 (Fig. S4).
Finally, the very strong anti-proliferative effect of hsa-miR-1 in
Wnt/b-catenin dependent human cancer cells (HT29) but not in
HEK293 cells, combined with its strong inhibitory effect on an in
vivo Wnt-reporter in primary mammary epithelial organoids
(Fig. 5), and its lack of known oncogenic properties, highlight its
potential as a novel miRNA-based candidate for the development
of anti-cancer therapies. Upstream inhibitors like miR-1 besides
downstream inhibitors like miR-25 thus show interesting proper-
ties for anti-cancer treatments in Wnt-dependent cancers and
further support current findings that upstream components of the
Wnt pathway are also valid and rational targets for cancer-
therapies, even in cells with downstream mutations [15],[54],[55].
In summary our study reports the first comprehensive
identification of Wnt-modulating miRs in human cells and
represents how miR-based HTS can be employed as a powerful
tool to systematically identify pathway relevant miRs. Since
pathway-modulatory miRs could have functional impact in
cancers associated with deregulated cell signaling, these findings
could also benefit the long-term goal of developing miR-based
therapeutics and for the diagnostic classification of cancers by
expression profile signatures.
Supporting Information
Figure S1 Results of the primary Wnt/miR screen. (A)
Summarized target listing of cherrypick miRs identified as Wnt-
modulating in a primary STF19x-based reporter screen in
HEK293 cells. (B) Representative section of the primary screen
showing the average of quadruplets as normalized values (STF19x
TCF-sites firefly divided by CMV-driven Renilla internal control).
Identified target miRs are indicated. (C) Graph showing sorted Z-
score values of logarithmized screen data for better comparability.
(D) Z-Score of log-transformed screen data (LOG-Z) (green), linear
regression on values of unchanged values (red), its subtraction form
LOG-Z, and division by 0.56 for a better visual representation
(blue). Estimation of about 160 (34%) Wnt-modulating miRs with
noise exceeding z-score average values, 80 activators and 80
repressors, respectively. Please note: Anticipating a validation rate
of 63.3% (see main text) would yield 101 miRs in the library that
modulate the Wnt pathway, representing 21,5%.
(TIF)
Figure S2 Alignment and phylogenetic quartet puzzling
trees of investigated miR families (A) Mature and stem-loop
miR strand alignment and tree of members of the miR-1/206
family. (B) Mature and stem-loop alignment of members of the
miR-25/92 family.
(TIF)
Figure S3 Alignment and phylogenetic quartet puzzling
tree of all validated Wnt3a-modulating stem-loop miRs
identified. (A) Phylogenetic tree of the alignment. Light green:
Inhibitor Stem-Loop (SL)-miR similarity group. Light-red:
activating SL-miR similarity group. Inset: Quantification of SL-
and mature miRs that show the same effect on the canonical Wnt
pathway. (B) Alignment of all validated Wnt-modulating SL-miR
sequences using ClustalW. (C) Comparison and visualization of
the similarity groups identified for stem-loop and mature miRs and
their effect on the canonical Wnt pathway.
(TIF)
Figure S4 Screening results and alignment of studied
miRs (miR-1/206 and miR-25/92 family) and miRs with
a similar seed sequence. (A) STF19x/CMV-RL reporter
values measured in the primary screen for miR-1/206 related
miRs inheriting the GGAAUGU seed sequence and their
alignment. (B) STF19x/CMV-RL reporter values measured in
the primary screen for miR-25/92 related miRs inheriting the
UUGCAC seed sequence and their alignment. Note that a few
nucleotide substitutions could affect modulation of the Wnt-
pathway as measured within the primary screen.
(TIF)
Figure S5 Possible miR-25 binding sites in b-catenin
CDS (543–1874) predicted with RNAhybrid and without
seed sequence constraints to include non-canonical seed
identification. Mfe: minimum free energy is indicated.
(TIF)
Figure/Table S6 Table with all data mining references
for the correlation studies of identified human Wnt-
regulatory miRs and their oncogenicity. (T1.R) Oncoge-
nicity of validated miR/Wnt-repressors. (T1.A) Oncogenicity of
validated miR/Wnt-synergizer miRs. (T2.R) Expressional changes
of validated miR/Wnt-repressors in cancer. (T2.A) Expression
changes of validated miR/Wnt-synergizers in cancer.
(DOCX)
Figure S7 Q-PCR result for b-catenin mRNA levels in
Hek293 cells transfected with 50 nM of indicated
synthetic Pre-miRs or control siRNAs in the presence
of 20 mM LiCl. Note: No significant changes of b-catenin
mRNA levels could be measured for all miRs tested.
(TIF)
Figure S8 Extraction of a consensus sequence of
identified miRs within the miR-515 and miR-302 family.
Alignment to identify a functional consensus in the miR-515
family and its overlap with modulators the miR-302 family in
regarding their ability to modulate the Wnt pathway. (A)
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PLoS ONE | www.plosone.org 10 October 2011 | Volume 6 | Issue 10 | e26257Alignment of all tested miR-515 family members in the primary
Wnt/miR-screen. (B) Tree of related miR-sequences with
normalized Wnt/miR-screen values and standard deviations
indicated (local plate average corrected). (C) Alignment of all
isolated Wnt-synergizing miR-515 family members to identify a
functional RNA consensus sequence that could be essential for the
activation-potential on the canonical Wnt pathway. Identification
of a common consensus sequence between the regulatory miR-515
and miR-203 family members (below).
(TIF)
Figure S9 Primary screen data including Nexp (STF-
19x/CMV-renilla), p-values, standard deviation, aver-
aged Nexp-values and list of estimated regulatory miRs.
A graph illustrates validated miRs within the whole screen data
(Nexp values).
(XLSX)
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